Former UFC heavyweight champ has been notified by the US Anti-Doping Agency of a failed out-of-competition medicine exam on 28 June
Brock Lesnar has been flagged for a potential anti-doping abuse in the wake of his unanimous-decision win over Mark Hunt at UFC 200.
The UFC issued a statement on Friday afternoon articulating Lesnar and the advertising had been notified by the US Anti-Doping Agency of a failed out-of-competition medication test on 28 June. Usada did not discovers the reputation of the substance Lesnar tested positive for in keeping with organizational policy.
A embellished amateur wrestler, Lesnar signed with the UFC in 2007 and thwarted Randy Couture for the advertisements heavyweight championship the subsequent year. He shaped two successful name securities before losing to Cain Velasquez by first-round TKO, then announced his retirement from mixed martial arts after a halt loss to Alistair Overeem in 2011.
Saturdays fight with Hunt was Lesnars first in 5 year. The 38 -year-old South Dakota native deserved a record $2.5 m handbag for the three-round items acquire, with all three judges handing down scores of 29 -2 8.
The UFC responded Usada, the independent head of the organizations anti-doping program, received the testing results from the 28 June sample collect on Thursday evening after it was experimented at the Wada-accredited UCLA Olympic Analytical Laboratory.
The original headline bout of Saturdays card a light-colored heavyweight entitlement oppose between Jon Jones and Daniel Cormier was scrapped when Jones are positive for a banned element. Cormier instead crusaded Anderson Silva on the undercard, while the status of women bantamweight championship campaign between Amanda Nunes and Miesha Tate was heightened to the main event.
The UFC 200 main event had to be scrapped three days before the occasion because Jon Jones are positive for censored essences in an out-of-competition test. Daniel Cormier campaigned Anderson Silva instead. Jones is also awaiting the USADA adjudication process.
Read more: www.theguardian.com